MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- YPrime, a proven leader in clinical trial technology, today announced it has been recognized as a Leader in the Everest Group’s Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025. The Leader designation reflects YPrime’s proven ability to deliver at scale across some of the industry’s most complex and time-sensitive clinical trials, powered by advanced technology, global scalability, and seamless operational exec ...